Sika AG
SIKA ACQUIRES MORTAR MANUFACTURER IN BRAZIL
Sika has agreed to acquire Supermassa do Brasil Ltda, a mortar manufacturer which operates under the brand BR Massa in the Brazilian market. The acquisition will enhance Sika’s position in the region of Minas Gerais, one of the strongest economic regions in Brazil, and complement the production footprint. The transaction is subject to clearance by the local anti-trust authorities.
The company holds a key market position in the region of Minas Gerais, mainly offering tile setting materials and facade mortars. BR Massa is a well-known local brand with a strong presence in the distribution channel. It will provide Sika with improved access to builders’ merchants and specialized dealers and lead to attractive cross-selling opportunities for Sika’s products through these channels. The acquisition complements the production footprint with a mortar manufacturing facility in a region where Sika has not previously had its own plant.
Christoph Ganz, Regional Manager Americas: "With BR Massa we will be able to better serve and supply our customers in the Minas Gerais region. The enhanced access to the distribution channel, supported by the expanded local supply chain, will contribute to the continued penetration of the Brazilian market. We warmly welcome the BR Massa employees to the Sika team and look forward to growing our business together".
CONTACT
Dominik Slappnig
Corporate Communications &
Investor Relations
+41 58 436 68 21
slappnig.dominik@ch.sika.com
SIKA CORPORATE PROFILE
Sika is a specialty chemicals company with a leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protecting in the building sector and motor vehicle industry. Sika has subsidiaries in 100 countries around the world and manufactures in over 300 factories. Its 25,000 employees generated annual sales of CHF 7.88 billion in 2020.
The media release can be downloaded from the following link:
Media Release
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG19.10.2025 16:30:00 CEST | Press release
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom